Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Systemic Inflammation Markers and Reverse T3 Levels in Patients With Hashimoto's Thyroiditis

NCT07510750 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT07510750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07510750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Systemic Inflammation Markers and Reverse T3 Levels in Patients With Hashimoto's Thyroiditis
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
August 20, 2025
Completion date
September 22, 2025
Enrollment
179 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hashimoto thyroiditis